2013 Threshold Change Created Gestational Hypertension Overnight

Gestational hypertension is rising across every demographic group in the country—Black women, white women, young mothers, older mothers, lean patients, obese patients—and the uniformity is the story's most unsettling feature.

When a disease balloons upward equally across every population simultaneously, you are not watching a biological epidemic. You are watching something change in how we measure.

In 2013, the American College of Obstetricians and Gynecologists lowered the diagnostic threshold for gestational hypertension from 160/110 millimeters of mercury to 140/90. That single decision created a new population of patients overnight—women whose blood pressure would have been ignored as normal under the old rule were now classified as sick under the new one.

This is not a small adjustment. It is the equivalent of expanding the net so drastically that you capture fish that were never swimming in deeper water. They were always there, just no longer invisible to your categories. And here is what makes it a real problem. Nobody in public health has seriously grappled with whether those newly diagnosed women actually needed to be treated differently, or whether we simply decided the number 140/90 mattered more than evidence suggested it did.

We moved the goal posts and then acted shocked that more people were now out of bounds.

The field treats this as settled—obstetricians invoke the guideline as though it emerged from nature rather than from a committee vote, pregnant women internalize the diagnosis, health systems scale interventions around it. But the evidence that prompted the threshold change was thin, designed for non-pregnant populations. Built on studies that conflated blood pressure readings with actual risk to mother or baby. We moved the goal posts and then acted shocked that more people were now out of bounds. The real question is not whether gestational hypertension exists or matters. Whether we have accidentally turned a measure into a disease—whether we have created patients who would have lived their entire pregnancies without complication, now monitoring a number instead of their actual experience. In any other field, when you expand a definition and the prevalence skyrockets across every group simultaneously, you pause and ask whether you just changed the thing you were measuring rather than discovered more of it.

In obstetrics, we kept walking. That gap between what the data shows and what we've decided to do about it is where the real problem lives.